Jilin Aodong Pharmaceutical Hits Day Low Amid Price Pressure at CNY 17.98

Jilin Aodong Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 3.64% as it reached an intraday low of CNY 17.98. This performance contrasts with the broader market, as the China Shanghai Composite index fell by only 1.24% on the same day. Over the past week, Jilin Aodong's stock has decreased by 3.95%, while its one-month performance shows a decline of 2.49%. Year-to-date, the stock has faced a more significant drop of 7.94%, compared to the China Shanghai Composite's slight decrease of 0.3%. Despite these short-term fluctuations, Jilin Aodong has shown resilience over the longer term, with a one-year performance of 6.58%. The company has reported a substantial net profit growth of 38.53% and has achieved its highest operating cash flow of CNY 1,052.08 million. With a market capitalization of CNY 21,378 million, Jilin Aodong remains a significant player in the pharmaceuticals and biotechnology sector.